Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Cosmetics
(AREA)
Abstract
The invention relates to the treatment of androgenic alopecia. The oral pharmaceutical composition for treating androgenic alopecia comprises the inhibitor of 55-reductase at a dose of 0.05-3.0 mg.
UA96041480A1993-10-151994-10-11PHARMACEUTICAL COMPOSITION FOR TREATING ANDROGENIC ALOPECIA USING INHIBITOR OF 5<font face="Symbol">a</font>-REDUCTASE
UA41376C2
(en)
THE USE OF 17 ß -(N-TERT-BUTYLCARBAMOYIL)-4-AZA-5-ALPHA-ANDROST-1-ENE-3-ONE FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF ANDROGENIC ALOPECIA